checkmate 8hw: first-line nivolumab plus ipilimumab in msi-h/dmmr mcrc
Published 1 month ago • 106 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:11
checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
2:02
hrqol findings from checkmate 8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
0:59
checkmate 8hw: hrqol outcomes of nivolumab and ipilimumab in msi-h/dmmr mcrc
-
0:43
keynote-177 and checkmate 8hw: promising first-line immunotherapy for msi-h mcrc
-
3:24
checkmate 8hw: nivolumab plus ipilimumab versus chemotherapy for metastatic colorectal cancer
-
1:11
remaining questions for the treatment of patients with msi/dmmr mcrc with immunotherapy
-
5:59
nivolumab plus low-dose ipilimumab promising for treatment-naïve msi-high mcrc | heinz-josef lenz
-
1:41
recist and irecist criteria for the evaluation of nivolumab ipilimumab in msi/dmmr mcrc
-
1:11
nivolumab/ipilimumab combination data promising in msi-h/dmmr mcrc
-
3:44
keynote-177 & checkmate 142: checkpoint blockade in msi-h/dmmr crc
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
1:43
nivolumab, ipilimumab and panitumumab in mcrc
-
2:03
promising checkmate-142 data for second-line ipilimumab plus nivolumab in mcrc
-
2:11
pembrolizumab vs. chemo in first-line mcrc
-
5:10
checkmate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for rcc
-
2:37
moving forward with results from checkmate-142 in msi-h mcrc
-
1:03
dr. nelson on the checkmate-142 trial in msi-h/dmmr mcrc
-
1:54
dr. lenz on updated data from checkmate 142 with nivolumab ipilimumab in mcrc